CN114269373A - 抗原性多聚呼吸道合胞病毒多肽 - Google Patents
抗原性多聚呼吸道合胞病毒多肽 Download PDFInfo
- Publication number
- CN114269373A CN114269373A CN202080039105.1A CN202080039105A CN114269373A CN 114269373 A CN114269373 A CN 114269373A CN 202080039105 A CN202080039105 A CN 202080039105A CN 114269373 A CN114269373 A CN 114269373A
- Authority
- CN
- China
- Prior art keywords
- rsv
- polypeptide
- gcc
- ser
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18571—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210425428.5A CN114957407A (zh) | 2019-04-02 | 2020-04-01 | 抗原性多聚呼吸道合胞病毒多肽 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828302P | 2019-04-02 | 2019-04-02 | |
| US62/828,302 | 2019-04-02 | ||
| PCT/US2020/026198 WO2020205986A1 (en) | 2019-04-02 | 2020-04-01 | Antigenic multimeric respiratory syncytial virus polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210425428.5A Division CN114957407A (zh) | 2019-04-02 | 2020-04-01 | 抗原性多聚呼吸道合胞病毒多肽 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114269373A true CN114269373A (zh) | 2022-04-01 |
Family
ID=70465435
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080039105.1A Pending CN114269373A (zh) | 2019-04-02 | 2020-04-01 | 抗原性多聚呼吸道合胞病毒多肽 |
| CN202210425428.5A Pending CN114957407A (zh) | 2019-04-02 | 2020-04-01 | 抗原性多聚呼吸道合胞病毒多肽 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210425428.5A Pending CN114957407A (zh) | 2019-04-02 | 2020-04-01 | 抗原性多聚呼吸道合胞病毒多肽 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12454553B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3946446A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7657727B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN114269373A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020205986A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114957407A (zh) * | 2019-04-02 | 2022-08-30 | 赛诺菲 | 抗原性多聚呼吸道合胞病毒多肽 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11608458B2 (en) | 2019-12-19 | 2023-03-21 | Prc-Desoto International, Inc. | Adhesion-promoting interlayer compositions containing organic titanates/zirconates and methods of use |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| ATE178906T1 (de) * | 1994-08-25 | 1999-04-15 | Stichting Inst Dierhouderij | Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen |
| AUPO026596A0 (en) | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
| CA2281838A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| EP1003531B1 (en) | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| US6218371B1 (en) | 1998-04-03 | 2001-04-17 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| KR100938105B1 (ko) * | 2007-09-21 | 2010-01-21 | 이화여자대학교 산학협력단 | 호흡기 신시치아 바이러스 백신 |
| WO2010075491A2 (en) * | 2008-12-24 | 2010-07-01 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
| US9060975B2 (en) | 2013-03-14 | 2015-06-23 | Mucosis Bv | Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions |
| US9703095B2 (en) | 2015-01-05 | 2017-07-11 | Edward Pakhchyan | Light modulator for MEMS display |
| WO2016160166A1 (en) * | 2015-03-30 | 2016-10-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunogenic rsv polypeptides |
| US20180271970A1 (en) * | 2015-10-22 | 2018-09-27 | Modernatx, Inc. | Respiratory syncytial virus vaccine |
| KR102724939B1 (ko) | 2016-06-17 | 2024-11-01 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 선형 또는 분지형 폴리아크릴산 폴리머 아쥬반트를 포함하는 신규한 면역원성 제형 |
| EP3585428A1 (en) * | 2017-02-23 | 2020-01-01 | Alpha-o Peptides AG | Self-assembling protein nanoparticles encapsulating immunostimulatory nucleid acids |
| CN111405907B (zh) | 2017-08-07 | 2024-10-01 | 考尔德生物科技有限公司 | 构象稳定的rsv预融合f蛋白 |
| EP3681523A4 (en) * | 2017-09-15 | 2021-12-29 | The Ohio State Innovation Foundation | Vaccines and methods of making and using vaccines for prevention of respiratory syncytial virus (rsv) infections |
| EP3773698A1 (en) * | 2018-04-03 | 2021-02-17 | Sanofi | Ferritin proteins |
| JP7657727B2 (ja) * | 2019-04-02 | 2025-04-07 | サノフイ | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
-
2020
- 2020-04-01 JP JP2021558831A patent/JP7657727B2/ja active Active
- 2020-04-01 EP EP20722065.8A patent/EP3946446A1/en active Pending
- 2020-04-01 CN CN202080039105.1A patent/CN114269373A/zh active Pending
- 2020-04-01 CN CN202210425428.5A patent/CN114957407A/zh active Pending
- 2020-04-01 WO PCT/US2020/026198 patent/WO2020205986A1/en not_active Ceased
-
2021
- 2021-09-29 US US17/489,249 patent/US12454553B2/en active Active
-
2025
- 2025-01-10 JP JP2025003856A patent/JP2025063151A/ja active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114957407A (zh) * | 2019-04-02 | 2022-08-30 | 赛诺菲 | 抗原性多聚呼吸道合胞病毒多肽 |
| US12454553B2 (en) | 2019-04-02 | 2025-10-28 | Sanofi | Antigenic multimeric respiratory syncytial virus polypeptides |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022525431A (ja) | 2022-05-13 |
| CN114957407A (zh) | 2022-08-30 |
| JP7657727B2 (ja) | 2025-04-07 |
| WO2020205986A1 (en) | 2020-10-08 |
| US12454553B2 (en) | 2025-10-28 |
| JP2025063151A (ja) | 2025-04-15 |
| US20220119457A1 (en) | 2022-04-21 |
| EP3946446A1 (en) | 2022-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102964264B1 (ko) | 항원성 호흡기 세포융합 바이러스 폴리펩타이드 | |
| US20240216497A1 (en) | Ferritin Proteins | |
| JP6469081B2 (ja) | 安定化された可溶性融合前rsvfポリペプチド | |
| KR102252163B1 (ko) | 인플루엔자 바이러스 백신 및 그의 용도 | |
| JP2025063151A (ja) | 抗原性多量体呼吸器合胞体ウイルスポリペプチド | |
| KR20200113226A (ko) | 인플루엔자 바이러스 백신 및 이의 용도 | |
| JPWO2010092963A1 (ja) | 薬物運搬体並びにこれを利用したアジュバントおよびワクチン | |
| AU2020325279B2 (en) | Methods and compositions for stabilized recombinant flavivirus E protein dimers | |
| JP2024502823A (ja) | 安定なコロナウィルスタンパク質およびそのワクチン組成物 | |
| KR20220062080A (ko) | 전립선암 치료를 위한 면역요법 | |
| CN118176204A (zh) | 截短的流感神经氨酸酶及其使用方法 | |
| RU2807992C2 (ru) | Антигенные полипептиды на основе последовательности респираторно-синцитиального вируса | |
| CA2886189A1 (en) | Polypeptides and their use in treating metapneumovirus (mpv) infection | |
| CN117177774A (zh) | Sars-cov-2受体结合结构域与载体蛋白的共价缀合物以及包含它们的疫苗组合物 | |
| CN116761624A (zh) | 稳定的冠状病毒蛋白及其疫苗组合物 | |
| EA048316B1 (ru) | Ковалентные конъюгаты рецептор-связывающего домена sars-cov-2 и белка-носителя и содержащие их вакцинные композиции | |
| NZ752808A (en) | Stabilized soluble prefusion rsv f polypeptides | |
| JP2014508144A (ja) | 免疫応答を刺激するためのプラットフォーム技術を利用するコンジュゲート | |
| NZ713371B2 (en) | Stabilized soluble prefusion rsv f polypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |